News

Supply chain leaders gather in Philadelphia in October

PDUFA reauthorization creates new pathways; GAO report notes FDA’s 99% acceptance rate for expanded access

Global supply chain issues in distribution bring senior execs together

Sales Compensation Solutions, a new book from ZS Associates, outlines problems and solutions

A direct-distribution model could save expense for payers and patients while providing better service

A better way to reverse the cryopreservation common in cellular therapies

A 60% increase in pallet storage capability

Master data on prescribers is combined with tracking expenditures, for transparency reporting

First gene therapy product in US; approval expedited by evidence of high cure rates

Investors hope for a repeat of Gilead’s Sovaldi success

Company is targeting a treatment for glioblastoma; Phase I to begin next year

Pharma needs better internal policies to manage its increasing patient interaction

In the midst of the opioid crisis, drug distributors need to address DEA oversight

Observers are critical of the $465-million penalty as too lenient

Leading CRO looks to better trial recruitment, outcomes research

Is the accelerated-approval process providing a net benefit to patients?

Specialized conditioning technology simplifies the shipment prep work

CEIV Pharma certification; expanded temperature regimes and better calibration capabilities

A protest against not protesting; unclear consequences for pharma’s place on the White House council

Oncology, obesity control and respiratory therapy are the first targets

New location, following Brexit, will be decided in November

Firm has quintupled its Indianapolis facility over two years

Pharma traceability company will expand global presence

Meanwhile, opioid manufacturers and distributors contend with multiple DEA penalties

Action better integrates warehouse operations into pharma traceability

Electronic signatures, a call-center telephony system and secure fax technology are being provided

Site lists manufacturers’ policies and criteria for experimental access